BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26624995)

  • 41. Interplay of mitochondrial metabolism and microRNAs.
    Geiger J; Dalgaard LT
    Cell Mol Life Sci; 2017 Feb; 74(4):631-646. PubMed ID: 27563705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-17-92 regulates myoblast proliferation and differentiation by targeting the ENH1/Id1 signaling axis.
    Qiu H; Liu N; Luo L; Zhong J; Tang Z; Kang K; Qu J; Peng W; Liu L; Li L; Gou D
    Cell Death Differ; 2016 Oct; 23(10):1658-69. PubMed ID: 27315298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing microRNAs with vector-encoded decoy-type inhibitors.
    Bak RO; Hollensen AK; Mikkelsen JG
    Mol Ther; 2013 Aug; 21(8):1478-85. PubMed ID: 23752312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition.
    Qiu H; Zhong J; Luo L; Liu N; Kang K; Qu J; Peng W; Gou D
    PLoS One; 2015; 10(12):e0143864. PubMed ID: 26624995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of Efficient miRNA Inhibitors Using Tough Decoy Constructs.
    Yoo J; Hajjar RJ; Jeong D
    Methods Mol Biol; 2017; 1521():41-53. PubMed ID: 27910040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.
    Sakurai F; Furukawa N; Higuchi M; Okamoto S; Ono K; Yoshida T; Kondoh M; Yagi K; Sakamoto N; Katayama K; Mizuguchi H
    Virus Res; 2012 May; 165(2):214-8. PubMed ID: 22342424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges.
    Hollensen AK; Thomsen R; Bak RO; Petersen CC; Ermegaard ER; Aagaard L; Damgaard CK; Mikkelsen JG
    RNA; 2017 Aug; 23(8):1247-1258. PubMed ID: 28487381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant expression of microRNAs in bladder cancer.
    Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
    Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.
    Yu X; Zhen Y; Yang H; Wang H; Zhou Y; Wang E; Marincola FM; Mai C; Chen Y; Wei H; Song Y; Lyu X; Ye Y; Cai L; Wu Q; Zhao M; Hua S; Fu Q; Zhang Y; Yao K; Liu Z; Li X; Fang W
    Cell Death Dis; 2013 May; 4(5):e634. PubMed ID: 23681229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.
    Furuta M; Kozaki K; Tanimoto K; Tanaka S; Arii S; Shimamura T; Niida A; Miyano S; Inazawa J
    PLoS One; 2013; 8(3):e60155. PubMed ID: 23544130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors.
    Hollensen AK; Bak RO; Haslund D; Mikkelsen JG
    RNA Biol; 2013 Mar; 10(3):406-14. PubMed ID: 23324610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.
    Bak RO; Hollensen AK; Primo MN; Sørensen CD; Mikkelsen JG
    RNA; 2013 Feb; 19(2):280-93. PubMed ID: 23249752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity.
    Kang K; Zhang X; Liu H; Wang Z; Zhong J; Huang Z; Peng X; Zeng Y; Wang Y; Yang Y; Luo J; Gou D
    PLoS One; 2012; 7(11):e48536. PubMed ID: 23152780
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.